Strategic Blueprint’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-608
Closed -$213K 660
2025
Q4
$213K Sell
608
-81
-12% -$27.4K 0.01% 616
2025
Q3
$223K Buy
+689
New +$214K 0.01% 676
2025
Q2
Sell
-460
Closed -$200K 692
2025
Q1
$200K Buy
+460
New +$185K 0.01% 656
2024
Q4
Sell
-560
Closed -$291K 671
2024
Q3
$291K Buy
560
+18
+3% +$9.62K 0.02% 519
2024
Q2
$294K Buy
542
+32
+6% +$16.9K 0.02% 499
2024
Q1
$264K Sell
510
-91
-15% -$45.3K 0.02% 518
2023
Q4
$283K Sell
601
-5
-0.8% -$2.31K 0.02% 471
2023
Q3
$264K Sell
606
-29
-5% -$13.2K 0.02% 449
2023
Q2
$282K Sell
635
-75
-11% -$34.6K 0.03% 439
2023
Q1
$327K Sell
710
-90
-11% -$42.8K 0.03% 388
2022
Q4
$411K Buy
800
+6
+0.8% +$3.05K 0.05% 333
2022
Q3
$361K Sell
794
-74
-9% -$35.4K 0.04% 330
2022
Q2
$419K Buy
868
+4
+0.5% +$1.98K 0.05% 311
2022
Q1
$424K Sell
864
-16
-2% -$7.31K 0.05% 312
2021
Q4
$408K Sell
880
-45
-5% -$18.9K 0.05% 309
2021
Q3
$345K Buy
925
+526
+132% +$200K 0.05% 304
2021
Q2
$152K Buy
+399
New +$152K 0.02% 418
2019
Q4
Sell
-304
Closed -$73K 184
2019
Q3
$73K Buy
+304
New +$83.3K 0.06% 126

Other funds holding ELV

Strategic Blueprint's ELV Position: Q1 2026 in Review

Strategic Blueprint sold out of Elevance Health (ELV) in Q1 2026, closing a stake of 608 shares — an estimated $213K sold.

Strategic Blueprint first reported a position in ELV in Q3 2019 and held it in 18 quarters. The position peaked at $424K in Q1 2022. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Strategic Blueprint reported no remaining Elevance Health position as of Q1 2026 after selling out during the quarter.
  • Strategic Blueprint sold 608 Elevance Health shares in Q1 2026, an estimated $213K.
  • Strategic Blueprint first reported a position in Elevance Health in Q3 2019 and held it in 18 quarters.
  • Strategic Blueprint's Elevance Health position peaked at $424K in Q1 2022.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Strategic Blueprint's 13F filing for Q1 2026, filed 29 Apr 2026.